Thermo Fisher Scientific | TMO - Operating Expenses

Stock Price
469.71
Daily Change
3.01 0.64%
Monthly
-4.29%
Yearly
10.72%
Q2 Forecast
459.66

Thermo Fisher Scientific reported $9.09B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Agilent USD 1.44B 27M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 423M 1.06B Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
General Electric Aerospace USD 18.06B 7.11B Mar/2026
Henry Schein USD 3.25B 110M Dec/2025
Illumina USD 903M 69M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 212.8M 16.2M Dec/2025
Olympus JPY 233.04B 18.77B Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quest Diagnostics USD 2.5B 76M Mar/2026
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Veracyte USD 116M 7.24M Dec/2025
Waters USD 661.85M 1.67B Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025